111: Lenalidomide Directly Upregulates NK (Natural Killer) Cell Trail and Granzyme B Expression: Implications for Adoptive NK Cell Immunotherapy following Allogeneic Hematopoietic Stem Cell Transplantation (HCT)

Files
Srivastava2008Lenalidomide-CCBYNCND.pdf (50.53 KB)
Date
2008-02-01
Authors
Srivastava, S.
Lundqvist, A.
Berg, M.
Yokoyama, H.
Smith, A.
Language
English
Embargo Lift Date
Department
Medicine, School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Elsevier
Abstract
Description
Keywords
Hematopoietic Stem Cell Transplantation (HCT), Adoptive NK Cell Immunotherapy, Granzyme B Expression
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Srivastava, S., Lundqvist, A., Berg, M., Yokoyama, H., Smith, A., McCoy, J. P., & Childs, R. (2008). 111: Lenalidomide Directly Upregulates NK (Natural Killer) Cell Trail and Granzyme B Expression: Implications for Adoptive NK Cell Immunotherapy following Allogeneic Hematopoietic Stem Cell Transplantation (HCT). Biology of Blood and Marrow Transplantation, 14(2, Supplement), 43. https://doi.org/10.1016/j.bbmt.2007.12.120
ISSN
1083-8791
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Biology of Blood and Marrow Transplantation
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International Creative Commons licenses
Source
Publisher
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/30683
DOI
https://doi.org/10.1016/j.bbmt.2007.12.120
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles
Department of Medicine Works